Female pattern hair loss (FPHL) is the most common cause of thinning hair in women, producing gradual loss of density over the crown while the frontal hairline is usually preserved. Minoxidil is the mainstay of treatment, with anti-androgens added in selected cases.
Female pattern hair loss, the term often preferred over "androgenetic alopecia" in women because the hormonal link is less clear-cut than in men, is a chronic condition driven by genetic susceptibility and, in many women, follicle sensitivity to androgens. Over time, affected follicles undergo miniaturization, producing progressively finer, shorter hairs and reduced overall density.
How it typically presents
The classic pattern is diffuse thinning over the central scalp and crown, often first noticed as a widening center part, while the frontal hairline is generally retained. It is usually gradual and not associated with patches, scarring, scalp pain, or redness. Sudden loss, distinct bald patches, or scalp symptoms point to a different diagnosis and warrant prompt evaluation.
What the evidence supports
Topical minoxidil is the only treatment FDA-approved for women and is first-line. It works by prolonging the growth phase of follicles; results take months and benefits are maintained only with continued use. Not everyone responds, and a meaningful minority see little improvement.
Anti-androgens such as oral spironolactone are used off-label, particularly when there are signs of excess androgens (acne, unwanted facial or body hair) or when minoxidil alone is insufficient. Evidence is more limited than for minoxidil, and these drugs require reliable contraception in women who could become pregnant. Low-dose oral minoxidil is an increasingly used off-label option prescribed by clinicians. Adjuncts such as low-level laser devices, microneedling, and platelet-rich plasma have some supportive data but weaker, more variable evidence.
The work-up
A dermatologist confirms the pattern through history and scalp examination, sometimes with dermoscopy. Blood tests are not always needed but may include iron studies (ferritin), thyroid function, and, when hyperandrogenism is suspected, hormone levels to look for conditions like PCOS.
What to expect from treatment
Hair regrowth is slow. Most treatments need at least 6 to 12 months of consistent use before a fair assessment, and the realistic goal is often to stabilize loss and modestly improve density rather than fully restore it. A temporary increase in shedding can occur in the first weeks of starting minoxidil and usually settles.
See a dermatologist if thinning is progressing, if you notice patchy loss, scaling, scarring, pain, or burning, or if hair loss is accompanied by symptoms such as irregular periods, severe acne, or rapid hair growth elsewhere. Early diagnosis improves the odds that treatment preserves the hair you still have.
Try the free self-check →FAQ
Is female pattern hair loss reversible?
It is generally not fully reversible, but it is often treatable and can be slowed or partially improved. Treatments like minoxidil work best at preserving existing follicles and stimulating modest regrowth, so starting earlier tends to give better results. Because benefits depend on ongoing use, stopping treatment usually leads to gradual return of thinning.
Do I need blood tests for female pattern hair loss?
Not always. The diagnosis is often made clinically from the pattern of thinning and scalp examination. However, a dermatologist may order tests such as ferritin (iron stores), thyroid function, or androgen levels if your history suggests an underlying contributor like low iron, thyroid disease, or a hormonal condition such as PCOS.
Explore more
⚠️ When to see a doctor — don’t self-treat
- Sudden patchy or circular bald spots
- Redness, scaling, pus, pain or itch (possible scarring alopecia — treat urgently)
- Broken hairs or rapid loss
- Loss with body-wide signs (weight loss, fatigue, cycle changes, acne, extra hair)
- Loss right after a new medication
- Any hair loss in a child